Announcements Trials

Browse Landscape

Phase

Status

Completed 3 Active not recruiting 2 Unknown 1 Terminated 1 Suspended 1 Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 6 Rectal Neoplasms 3 Lung Neoplasms 2 Carcinoma, Hepatocellular 2 Upper Tract Urothelial Carcinoma 1 Unresectable Hepatocellular Carcinoma 1 Turcot syndrome 1 Triple Negative Breast Neoplasms 1 Solid Tumor Cancer 1 Sarcoma 1 Radiation Injuries 1 Pathologic Complete Response 1 Pancreatic Cancer Liver Metastases 1 Neoadjuvant Immunotherapy 1 Muscle-invasive Bladder Cancer 1 Locally Advanced Rectal Adenocarcinoma 1 Locally Advanced Pancreatic Cancer 1 Locally Advanced Cervical Carcinoma 1 Hyperthermia 1 HER2-Negative Locally Advanced Breast Cancer 1 Gynecologic Cancers 1 Gastrointestinal Neoplasms 1 Gastric Cancer With Liver Metastases 1 Esophageal Squamous Cell Carcinoma 1 Efficacy and Safety of Short-course Radiotherapy in Total Neoadjuvant Therapy Combined With Enlonstobart for pMMR Locally Advanced Rectal Cancer 1 Colorectal Neoplasms 1 Carcinoma 1 Breast Neoplasms 1 Advanced Rectal Cancer 1

Interventions

Trastuzumab 16 pertuzumab 14 Capecitabine 14 Docetaxel 12 pyrotinib 11 Cyclophosphamide 11 Standard of Care 10 Paclitaxel 10 Letrozole 10 trastuzumab deruxtecan 9 Radiotherapy 9 Carboplatin 9 Fulvestrant 8 Drug Therapy 8 sacituzumab govitecan 7 dalpiciclib 7 exemestane 6 eribulin 6 Tamoxifen 6 Epirubicin 6 Anastrozole 6 pembrolizumab 5 palbociclib 5 abemaciclib 5 Surveys and Questionnaires 5 Neoadjuvant Therapy 5 Aromatase Inhibitors 5 camrelizumab 4 Sentinel Lymph Node Biopsy 4 Doxorubicin 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × Breast Neoplasms × Immunotherapy × Clear all

NCT07254858 2025-11-28

CISN-L

First Affiliated Hospital of Wenzhou Medical University

Phase 2 Not yet recruiting

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡